We recently wrote about the disappointing results and less-than-inspiring strategy to turn the ship around at Butterfly Network (BFLY). The medical device company has developed a game-changing handheld ultrasound probe powered by artificial intelligence, but is struggling mightily to hit high-growth revenue targets while bleeding money like a high-growth tech stock. In our last article, we officially put Butterfly Network stock on double-secret probation and will switch it from “like” to “avoid” if it doesn’t hit certain milestones at the next check-in. iRhythm stock (IRTC) is another medical device stock on the bubble. Is it another bust or ready to finally boom?
iRhythm Stock Today
It’s been a couple of years since we last checked in with iRhythm stock when we discussed whether it was finally time to buy. It wasn’t. The total addressable market (TAM) see